Skip to main content
. 2021 Apr 2;100(13):e25011. doi: 10.1097/MD.0000000000025011

Table 1.

Baseline demographic factors, comorbidities, and outcome among the randomly assigned supplementation and placebo groups.

Variable D3 Supplementation group (n = 93) Placebo group (n = 98) P
Age, mo 24 (18--48) 24 (10--48) .613
Sex
 Male 65 (69.9) 71 (72.4) .697
 Female 28 (30.1) 27 (27.6)
Ever breast fed 71 (76.3) 78 (79.6) .588
Bottle fed
 Cow milk 43 (46.2) 49 (50) .603
 Artificial milk 50 (53.8) 49 (50)
Age of weaning, mo 8 (6–12) 7 (6 - 9) .348
Cow milk intake after weaning
 < 250 mL/day 47 (50.5) 50 (51) .931
 250–500 mL/day 38 (40.9) 41 (41.8)
 > 500 mL/day 8 (8.6) 7 (7.1)
No. of children in house 3 (2–3) 3 (2–3) .428
Maternal age, yr 32 (30–35) 32 (30–35) .892
Maternal education
 Not educated 9 (9.7) 16 (16.3) .315
 Primary education 43 (46.2) 46 (46.9)
 Secondary education 34 (36.6) 33 (33.7)
 High education 7 (7.5) 3 (3.1)
Exposure to sun
 Less frequent 25 (26.9) 28 (28.6) .794
 More frequent (most of days) 68 (73.1) 70 (71.4)
Comorbidities 48 (51.6) 42 (42.9) .226
Severe pneumonia 64 (68.8) 60 (61.2) .272
Duration of hospital stay, d 11 (10--14) 10 (8 - 13) .001
Total duration of stay
 < 2 wks 67 (72) 75 (76.5) .478
 2 wks or more 26 (28) 23 (23.5)
Mortality 23 (24.7) 32 (32.7) .227

Qualitative variables described as number (percentage). Quantitative variables described as median (interquartile range).

Bold values represent statistically significant P values were below .05.

Mann--Whitney test.

Chi-square test.